IL6 and prostate carcinoma: Interleukin 6 (IL-6) is an anti-inflammatory myokine that has been found to activate AR-mediated gene expression via a signal transducer and activator of transcription 3 (Stat3) activator pathway in prostate carcinoma cells [38,39].